Tumor markers used in GC patients as prognostic factors and a close relationship with specific cancers such as CEA, CA19-9 and CA72-4 and cancer antigen 125, to play an important roles in predicting recurrence, metastasis and evaluating prognosis of GC [19–23]. Here, MUC16 is linked to neoplasm.